Context Therapeutics Inc (CNTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 25,138 | 29,769 | 35,497 | 39,427 | 42,921 |
| TOTAL | $27,709 | $31,886 | $37,854 | $41,939 | $44,500 |
| Non-Current Assets | |||||
| PPE Net | 21 | 24 | 28 | 31 | 34 |
| Other Non-Current Assets | 32 | 56 | 85 | 113 | 163 |
| TOTAL | $53 | $81 | $112 | $144 | $197 |
| Total Assets | $27,762 | $31,966 | $37,966 | $42,083 | $44,697 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,191 | 1,210 | 936 | 1,495 | 946 |
| Accrued Expenses | 2,559 | 1,991 | 2,216 | 2,438 | 2,001 |
| TOTAL | $3,758 | $3,233 | $3,208 | $4,012 | $3,040 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 8 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $8 |
| Total Liabilities | $3,758 | $3,233 | $3,208 | $4,012 | $3,048 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 15,966 | 15,966 | 15,966 | 15,966 | 15,966 |
| Common Shares | 16 | 16 | 16 | 16 | 16 |
| Retained earnings | -55,410 | -50,399 | -44,090 | -40,534 | -36,679 |
| TOTAL | $24,005 | $28,733 | $34,758 | $38,072 | $41,649 |
| Total Liabilities And Equity | $27,762 | $31,966 | $37,966 | $42,083 | $44,697 |